Mydriasis

15 registered clinical trials studyying Mydriasis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Dr NCT07075224	Unither Pharmaceuticals, France	Phase 1 / Phase 2
Completed	Safety and Efficacy of Fixed Combination Phenylephrine-Tropicamide for Pupil Dilation NCT06217796	Eyenovia Inc.	Phase 4
Completed	Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Sub NCT05223478	Ocuphire Pharma, Inc.	Phase 3
Completed	Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Myd NCT05134974	Ocuphire Pharma, Inc.	Phase 3
Completed	Evaluation of Pupil Dilation Speed With the MAP Dispenser NCT04907474	Eyenovia Inc.	Phase 4
Completed	The Effects of Mydriatic Eye Drops in Retinopathy of Prematurity Examinations NCT05880433	Istanbul Training and Research Hospital	—
Completed	Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Myd NCT04620213	Ocuphire Pharma, Inc.	Phase 3
Unknown	Sutureless Intrascleral Intraocular Lens Fixation and Modified Iris Cerclage Pupilloplasty NCT05829122	Changzhou Second People's Hospital affiliated with Nanjing Medical University	N/A
Completed	Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis NCT04024891	Ocuphire Pharma, Inc.	Phase 2
Completed	Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Pha NCT04396301	Cairo University	Phase 3
Completed	Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation NCT03751098	Eyenovia Inc.	Phase 3
Completed	Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation NCT03751631	Eyenovia Inc.	Phase 3
Unknown	Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification NCT03638726	Dar El Oyoun Hospital	Phase 4
Completed	Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil NCT02946125	Eyenovia Inc.	Phase 2
Terminated	Intracameral Mydriasis Versus Topical Mydriasis in Cataract Surgery NCT00690222	Nova Scotia Health Authority	N/A